<html>
<head>PUBMED IDs for LZTS1</head>
<body bgcolor='#C5F0F2'><h1>LZTS1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/11464283/'>Functional identification of LZTS1 as a candidate prostate tumor suppressor gene on human chromosome 8p22.</a> July 21  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11504921/'>FEZ1/LZTS1 gene at 8p22 suppresses cancer cell growth and regulates mitosis.</a> August 16  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11943719/'>FEZ1/LZTS1 is down-regulated in high-grade bladder cancer, and its restoration suppresses tumorigenicity in transitional cell carcinoma cells.</a> April 12  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12114433/'>Differential expression of FEZ1/LZTS1 gene in lung cancers and their cell cultures.</a> July 13  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12377406/'>Germline sequence variants of the LZTS1 gene are associated with prostate cancer risk.</a> October 16  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12415013/'>The postsynaptic density and dendritic raft localization of PSD-Zip70, which contains an N-myristoylation sequence and leucine-zipper motifs.</a> November 5  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12851677/'>Down-regulation of FEZ1/LZTS1 gene with frequent loss of heterozygosity in oral squamous cell carcinomas.</a> July 10  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15735004/'>Reduced FEZ1/LZTS1 expression and outcome prediction in lung cancer.</a> March 1  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15876481/'>Mutation and expression analysis of LZTS1 in ovarian cancer.</a> May 7  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15922864/'>Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer.</a> June 1  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16012743/'>In silico characterization of LZTS3, a potential tumor suppressor.</a> July 14  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16918124/'>Molecular genetics of bladder cancer: targets for diagnosis and therapy.</a> August 22  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17127340/'>Chromosomal deletions in bladder cancer: shutting down pathways.</a> November 28  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17171680/'>Targets of genome copy number reduction in primary breast cancers identified by integrative genomics.</a> December 16  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17659810/'>DNA methylation profile of 28 potential marker loci in malignant mesothelioma.</a> July 31  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17873519/'>Take your &quot;M&quot; time.</a> September 18  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17889501/'>Identification of genes associated with tumorigenesis of meibomian cell carcinoma by microarray analysis.</a> September 25  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18192690/'>Fez1/Lzts1-deficient mice are more susceptible to N-butyl-N-(4-hydroxybutil) nitrosamine (BBN) carcinogenesis.</a> January 15  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18314628/'>[Mapping of a deletion interval on 8p21-22 in prostate cancer by gene dosage PCR].</a> March 5  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18686028/'>Down-regulation of tumor suppressor gene FEZ1/LZTS1 in breast carcinoma involves promoter methylation and associates with metastasis.</a> August 8  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19885841/'>FEZ1/LZTS1 protein expression in ovarian cancer.</a> December 18  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19885835/'>Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and risk for pancreatic adenocarcinoma.</a> March 10  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20083228/'>Genome-wide analysis of chromosomal alterations in patients with esophageal squamous cell carcinoma exposed to tobacco and betel quid from high-risk area in India.</a> September 14  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22893457/'>Activin and BMP4 synergistically promote formation of definitive endoderm in human embryonic stem cells.</a> December 21  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23695671/'>MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1.</a> January 1  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24448468/'>LZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancer.</a> February 24  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24525428/'>Targeting CDC25C, PLK1 and CHEK1 to overcome Docetaxel resistance induced by loss of LZTS1 in prostate cancer.</a> January 13  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24802407/'>miR-214 promotes the proliferation and invasion of osteosarcoma cells through direct suppression of LZTS1.</a> August 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25667121/'>The tumor-suppressor gene LZTS1 suppresses colorectal cancer proliferation through inhibition of the AKT-mTOR signaling pathway.</a> July 15  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25938461/'>MicroRNA-135b Regulates Leucine Zipper Tumor Suppressor 1 in Cutaneous Squamous Cell Carcinoma.</a> April 5  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26504261/'>Ehlers-Danlos Syndrome, Hypermobility Type, Is Linked to Chromosome 8p22-8p21.1 in an Extended Belgian Family.</a> July 28  2015<br></body></html>
